Drug intelligence / Profile preview

Disaccharide tripeptide glycerol dipalmitoyl

Development stage
Phase 2
Lead developer
ImmunoTherapeutics
Modality
Small Molecules
01

Overview

Disaccharide tripeptide glycerol dipalmitoyl (DTP-GDP) is a synthetic lipophilic disaccharide tripeptide derivative of muramyl dipeptide (MDP) with immunomodulatory activity. It stimulates macrophage activity and increases serum levels of various cytokines, including tumor necrosis factor alpha (TNF alpha), interleukin (IL)-1 alpha, IL-1 beta, IL-6, IL-8, and IL-12, potentially activating host immune system antitumor functions. It may be packaged in liposomes for improved delivery.

Brand names
ImmTher
Other names
N-acetylglucosamine-N-acetylmuramyl-alanyl-isoglutaminyl-alanyl-glycerol dipalmitoylL-alanine, N-(N-acetyl-4-O-(2-(acetylamino)-2-deoxy-β-D-glucopyranosyl)muramoyl)-L-alanyl-D-α-glutaminyl-, (2R)-2,3-bis((1-oxohexadecyl)oxy)propyl ester
02

Targets

IL8 (C-X-C Motif Chemokine Ligand 8)IL1B (Interleukin-1 beta)IL1A (Interleukin 1 alpha)IL-6 (Interleukin 6)IL12 (Interleukin-12)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Disaccharide tripeptide glycerol dipalmitoyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disaccharide tripeptide glycerol dipalmitoyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call